刮痧联合和乳汤治疗肝郁气滞型乳腺增生症临床观察

目的 观察刮痧联合疏肝行气中药治疗肝郁气滞型乳腺增生症的临床疗效。方法 将60例肝郁气滞型乳腺增生症患者随机分为对照组及观察组，每组30例，对照组患者口服和乳汤3个月，观察组患者口服和乳汤并接受刮痧治疗3个月。治疗前后分别采用超声观察乳腺的增生腺体厚度和增生肿块最大径，采用视觉模拟量表（visual analogue scale, VAS）评价乳房疼痛程度，采用焦虑自评量表（self-rating anxiety scale,SAS）和抑郁自评量表（self-rating depression scale,SDS）评价患者的焦虑、抑郁情绪。结果 与治疗前比较，治疗后两组患者乳房增生肿块最大径、增生腺体厚度显著缩小（P＜0.05），乳房疼痛VAS评分和SAS、SDS评分显著降低（P＜0.05），且观察组上述指标改善程度显著大于对照组（P＜0.05）。观察组临床疗效明显优于对照组（P＜0.05）。结论 刮痧联合和乳汤内服对肝郁气滞型乳腺增生症具有较好的疗效，并优于单纯和乳汤内服的疗效。

Clinical Effect of Scraping Therapy Combined with Heru Decoction in Treatment of Hyperplasia of Mammary Glands with Liver-Qi Stagnation Syndrome

Objective To investigate the clinical effect of scraping therapy combined with liver-soothing and Qi-moving traditional Chinese medicine in the treatment of hyperplasia of mammary glands with liver-Qi stagnation syndrome. Methods A total of 60 patients with hyperplasia of mammary glands with liver-Qi stagnation syndrome were randomly divided into control group and observation group, with 30 patients in each group. The patients in the control group were given oral administration of Heru Decoction for 3 months, and those in the observation group were given oral administration of Heru Decoction combined with scraping therapy for 3 months. Before and after treatment, ultrasound was used to measure gland thickness and the maximum diameter of proliferative mass; visual analogue scale (VAS) was used to observe the degree of breast pain, and self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were used to evaluate anxiety and depression. Results After treatment, both groups had significant reductions in gland thickness and the maximum diameter of proliferative mass (P<0.05), as well as significant reductions in VAS score of breast pain, SAS score, and SDS score (P<0.05), and the observation group had significantly greater reductions in the above indices than the control group (P<0.05). The observation group had a significantly better clinical outcome than the control group (P<0.05). Conclusion Scraping therapy combined with oral administration of Heru Decoction has a marked clinical effect in the treatment of hyperplasia of mammary glands with liver-Qi stagnation syndrome, and has a better clinical effect than oral administration of Heru Decoction alone.